Helsinn seeks SCOTUS review of patent case

Swiss-based pharmaceutical company Helsinn Healthcare has filed a petition for writ of certiorari with the US Supreme Court.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

SCOTUS agrees to hear on-sale bar battle

26 June 2018 The US Supreme Court has agreed to hear a dispute over whether confidential sales of an invention can trigger the on-sale bar and invalidate a patent under the America Invents Act.

Americas

Dr Reddy's found to infringe chemo drug patents

16 February 2017 The US District Court for the District of New Jersey has found that a generic version of Helsinn Healthcare's drug Aloxi that was proposed by Dr Reddy's infringes three patents for the drug.

More on this story

Americas

SCOTUS agrees to hear on-sale bar battle

26 June 2018 The US Supreme Court has agreed to hear a dispute over whether confidential sales of an invention can trigger the on-sale bar and invalidate a patent under the America Invents Act.

Americas

Dr Reddy's found to infringe chemo drug patents

More on this story

Americas

SCOTUS agrees to hear on-sale bar battle

26 June 2018 The US Supreme Court has agreed to hear a dispute over whether confidential sales of an invention can trigger the on-sale bar and invalidate a patent under the America Invents Act.

Americas

Dr Reddy's found to infringe chemo drug patents